ATPγS (tetralithium salt)
ATPγS (tetralithium salt) is a P2Y11 receptor agonist, an antioxidant and a neuroprotective agent. ATPγS (tetralithium salt) can be used as a substrate for the nucleotide hydrolysis and RNA unwinding activities of eukaryotic translation initiation factor eIF4A. ATPγS (tetralithium salt) is active in ATP hydrolysis[1][2][3][4][5].
Product Specifications
Product Name Alternative
Adenosine-5'-O- (3-thiotriphosphate) (tetralithium salt) ; Adenosine 5'-[γ-thio]triphosphate (tetralithium salt)
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Eukaryotic Initiation Factor (eIF) ; P2Y Receptor
Related Pathways
Cell Cycle/DNA Damage; GPCR/G Protein
Applications
COVID-19-anti-virus
Field of Research
Metabolic Disease; Inflammation/Immunology; Neurological Disease
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 75 mg/mL (ultrasonic)
Smiles
O[C@H]1[C@@H](O[C@H](COP(OP(OP(O[Li])(O[Li])=S)(O[Li])=O)(O[Li])=O)[C@H]1O)N2C3=C(C(N)=NC=N3)N=C2
Molecular Formula
C10H12Li4N5O12P3S
Molecular Weight
546.98
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-108666/ATPγS-tetralithium-salt-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EIF4
CAS Number
[93839-89-5]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items